Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance. - podcast episode cover

Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.

Dec 03, 20241 hr 9 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the recent years worked intensively in AMR and the similarities and differences with such crises. Tune in to hear his insights!

In the news section, we update you on our very very busy month of November, and bring you a really important paper demonstrating the relationship between rifaximin use and daptomicin resistance in Enterococcus.

Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance. | The AMR Studio podcast - Listen or read transcript on Metacast